Jump to content
  • Sign Up
0
Scott Adams

Alba Therapeutics Recruiting for a Phase 2b Clinical Trial and Gains Exclusive ... - MarketWatch (press release)

Rate this topic

Recommended Posts

Alba Therapeutics Recruiting for a Phase 2b Clinical Trial and Gains Exclusive ...

MarketWatch (press release)

"The CeD PRO questionnaire is an important tool for the continued development of larazotide acetate, our most advanced compound for the treatment of celiac disease," said Wendy Perrow, President and COO at Alba. "Understanding patients' perspectives on ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×